Finn Partners has acquired Medical & Health Consulting, Paris-headquartered firm that works for biopharma, technology and medical devices outfits, to bolster its position in Europe.
 |
|
Mina Volovitch, senior partner, Health, FINN Paris; Marie-Hélène Coste, MHC founding director and senior partner, Health, FINN Paris; and Gil Bashe, managing partner, FINN Global Health. |
Marie-Helene Coste, MHC founding director, will take on the role of senior director, health for Finn Europe. She will report to Chantal Bowman-Boyles, managing partner of Europe and Gil Bashe, managing partner of global health.
"MHC is one of France's most highly regarded medical device, life science and professional association consultancies and recognizes that when health professionals collaborate, the beneficiaries are the patients they seek to serve," Bashe told O'Dwyer's. "They are the ideal match for Finn in France."
Peter Finn noted that Coste and her firm "are renowned sector leaders and their work extends beyond France and Europe."
He called MHC a "perfect complement" to his firm's September acquisition of high-science healthcare firm Lazar Partners, a 22-member New York firm.
Finn Partners is O'Dwyer's No. 6-ranked healthcare company with $21.2M in fees in 2018.
Lo Isidro, senior director at Real Chemistry with more than a decade of strategic communications and PA experience, has joined Narrative Strategies.
Nelson Fernandez, former North American chair of APCO Worldwide and managing director of Burson-Marsteller, has joined Volunteers in Medicine Berkshires as director of communications and PA.
Lilit Bargar, who was most recently an EVP in the healthcare practice at Weber Shandwick, comes on board at GCI Health as EVP, corporate practice lead.
Five ways that successful thought leaders are made.
Have a comment? Send it to 
No comments have been submitted for this story yet.